Followers | 42 |
Posts | 5751 |
Boards Moderated | 0 |
Alias Born | 04/12/2021 |
Sunday, October 17, 2021 4:40:48 PM
“6:16a ET 8/10/2021 - Benzinga
Nautilus Biotechnology Q2 EPS $(0.19) Misses $(0.09) Estimate
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.09) by 111.11 percent.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
my posts are always theory and not financial advice
Recent NAUT News
- Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award • GlobeNewswire Inc. • 10/31/2024 12:00:00 PM
- Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference • GlobeNewswire Inc. • 10/30/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/29/2024 08:06:15 PM
- Nautilus Biotechnology Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/29/2024 12:00:00 PM
- Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 • GlobeNewswire Inc. • 10/08/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:47:37 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:40:38 PM
- Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer • GlobeNewswire Inc. • 09/17/2024 12:00:00 PM
- Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • GlobeNewswire Inc. • 08/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/30/2024 08:10:44 PM
- Nautilus Biotechnology Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/30/2024 12:00:00 PM
- Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:35:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:25:56 PM
- Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 05/23/2024 12:00:00 PM
- Nautilus Biotechnology Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/07/2024 05:15:12 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2024 09:39:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:49:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:46:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:42:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:34:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:30:01 PM
- Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
VAYK Renewed JV to Renovate Historic Landmark into "Most Sought-after Airbnb Place" in Downtown Atlanta • VAYK • Dec 12, 2024 9:36 AM
Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN • SLXN • Dec 11, 2024 9:22 AM
Actelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market.. • ASNS • Dec 11, 2024 8:30 AM
Consumer Automotive Finance, Inc. Cancels an Additional 50 Million Common Shares with Shareholder Commitment to Retire 250 Million More Common Shares • CAFI • Dec 10, 2024 1:30 PM
Strategic Investments Spark Renewed Interest in Multi-Club Ownership Models • MSGS • Dec 10, 2024 1:11 PM
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance • CAFI • Dec 9, 2024 9:30 AM